Vascular Endothelial Growth Factor (VEGF) isoform expression and activity in human and murine lung injury
Open Access
- 9 April 2009
- journal article
- Published by Springer Science and Business Media LLC in Respiratory Research
- Vol. 10 (1), 27
- https://doi.org/10.1186/1465-9921-10-27
Abstract
The properties of vascular endothelial growth factor (VEGF) as a potent vascular permogen and mitogen have led to investigation of its potential role in lung injury. Alternate spliced VEGF transcript generates several isoforms with potentially differing functions. The purpose of this study was to determine VEGF isoform expression and source in normal and ARDS subjects and investigate the expression and regulation of VEGF isoforms by human alveolar type 2 (ATII) cells. VEGF protein expression was assessed immunohistochemically in archival normal and ARDS human lung tissue. VEGF isoform mRNA expression was assessed in human and murine lung tissue. Purified ATII cells were cultured with proinflammatory cytokines prior to RNA extraction/cell supernatant sampling/proliferation assay. VEGF was expressed on alveolar epithelium, vascular endothelium and alveolar macrophages in normal and ARDS human lung tissue. Increases in VEGF expression were detected in later ARDS in comparison to both normal subjects and early ARDS (p < 0.001). VEGF121, VEGF165 and VEGF189 isoform mRNA expression increased in later ARDS (p < 0.05). The ratio of soluble to cell-associated isoforms was lower in early ARDS than normal subjects and later ARDS and also in murine lung injury. ATII cells constitutionally produced VEGF165 and VEGF121 protein which was increased by LPS (p < 0.05). VEGF165 upregulated ATII cell proliferation (p < 0.001) that was inhibited by soluble VEGF receptor 1 (sflt) (p < 0.05). These data demonstrate that changes in VEGF isoform expression occur in ARDS which may be related to their production by and mitogenic effect on ATII cells; with potentially significant clinical consequences.Keywords
This publication has 40 references indexed in Scilit:
- Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?Thorax, 2006
- Regulation of vascular endothelial growth factor bioactivity in patients with acute lung injuryThorax, 2005
- Decreased VEGF concentration in lung tissue and vascular injury during ARDSEuropean Respiratory Journal, 2005
- Effects of vascular endothelial growth factor on isolated fetal alveolar type II cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- The biology of VEGF and its receptorsNature Medicine, 2003
- VEGF regulates the proliferation of acid-exposed alveolar lining epithelial cellsThorax, 2003
- Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell linesin vitroEuropean Respiratory Journal, 2002
- The Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Report of the American-European consensus conference on ARDS: Definitions, mechanisms, relevant outcomes and clinical trial coordinationIntensive Care Medicine, 1994